TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences, Inc. in the Healthcare sector is trading at $4.73 with a market capitalization of $195M. Wall Street consensus targets $10.00 (4 analysts), implying a +111.4% move over the next 12 months. The stock is currently 41% below its 52-week high of $7.95, remaining 2.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 30 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.